AU2002217414A1 - Skin-protective compositions effective against vesicants and percutaneous chemical agents - Google Patents

Skin-protective compositions effective against vesicants and percutaneous chemical agents

Info

Publication number
AU2002217414A1
AU2002217414A1 AU2002217414A AU2002217414A AU2002217414A1 AU 2002217414 A1 AU2002217414 A1 AU 2002217414A1 AU 2002217414 A AU2002217414 A AU 2002217414A AU 2002217414 A AU2002217414 A AU 2002217414A AU 2002217414 A1 AU2002217414 A1 AU 2002217414A1
Authority
AU
Australia
Prior art keywords
protective agent
agent according
acid
protective
ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002217414A
Other versions
AU2002217414B2 (en
Inventor
Itzhak Barness
Eliezer Fishbine
Tamar Kadar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Israel Institute for Biological Research
Original Assignee
Israel Institute for Biological Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL142812A external-priority patent/IL142812A/en
Application filed by Israel Institute for Biological Research filed Critical Israel Institute for Biological Research
Publication of AU2002217414A1 publication Critical patent/AU2002217414A1/en
Application granted granted Critical
Publication of AU2002217414B2 publication Critical patent/AU2002217414B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Description

-i-
HIGH EFFICACY PROTECTIVE COMPOSITIONS AGAINST
VESICANTS AND PERCUTANEOUS CHEMICAL AGENTS
Field of the Invention
The invention relates to protective compositions for protecting the skin
against damages caused by sulfur mustard gas and other chemical agents,
such as VX, pesticides, nitrogen mustard and poison ivy.
Background of the Invention
Sulfur mustard (both in gaseous and liquid form) is a potent cutaneous
vesicant which rapidly penetrates tl. Askin and causes prolonged injuries,
and is therefore representative of the percutaneous agents to the
protection against which the present invention is directed. Sulfur
CH2 CH2 CI
S
\ CH2 CH2 CI
(I) mustard, as an example of major hazards consists of
β-chloro-diethylsulfide of the formula:
which may further contain other components, such as other active compounds.
VX as an example for nerve agent: 0-ethyl-S-(2-diisopropylaminoethyl-
methylphosphothiolate), of the formula:
O
I , 0CH2CH3
CH3 — p
^ S CH2 CH2N (CH (CH3)2) )2
There are two main ways known in the art of protecting a person's skin
against chemical warfare agents such as mustard: The first method is a
passive protection which involves covering the skin with a protective
cover, such as a protective cloth. This method has several drawbacks:
firstly, the protective clothings are heavy and uncomfortable to wear for a
long period of time, and therefore they cannot be continuously worn as a
preventive measure. Secondly, the protective covers leave areas
unprotected, such as the hands and neck, and therefore do not offer
complete protection. Furthermore, such protective measures are quite
expensive, which of course limits their usefulness.
The second method involves applying reactive materials to the skin, which
react with the sulfur mustard gas and neutralize it. The drawback
associated with this method is that it requires to apply to the skin active
materials which generally are in themselves harmful, typically require the
application of oily and uncomfortable materials to the skin, and furthermore are as yet only limited in efficacy. Additionally, such reactive
materials are also generally required in large amounts, which are difficult
to apply to the skin.
Other protections, which involve the use of creams which promote the
creation of a polymeric film on the skin are also not very effective, since
the film cracks and leaves areas below the cracks exposed. Furthermore,
such films are thick and uncomfortable to the user. Another cream exists,
which penetrates the skin, leaving an outer layer that can act as a matrix
for active protecting agents. This cream also exhibits the drawbacks
described above. In addition, this protective cream requires a thick layer
to be applied. The above composition may be toxic to the respiratory
system due to fumes emerging from smoking products, such as cigarettes,
and thus it is not effective in hot environments or where fire is present.
The art, notwithstanding the many efforts devoted to the solution of this
problem, has failed so far to provide a solution to the above problem, viz.,
a protection for the skin which overcomes the above drawbacks.
It is therefore an object of this invention to provide a protective agent
which is effective against sulfur mustard and other chemical agents, such
as VX, and which overcomes the drawbacks of prior art protections. It is another purpose of this invention to provide a protective agent which
can be applied to the skin often, which does not lead to discomfort, and
which is not harmful to the skin.
It is yet another purpose of the invention to provide a protective agent
which remains effective for a long period of time after application, in the
order of 6 - 12 hours before exposure to the harmful chemical agent.
Other purposes and advantages of this invention will appear as the
description proceeds.
Summary of the Invention
The invention is directed to a protective agent suitable to protect the
human skin against sulfur mustard gas injury, nerve agents such as VX
and injury from other harmful chemical agents, comprising a
protective-effective amount of a hydrophilic water-based cream, alone or
together with one or more additives selected from among the group
consisting essentially of polyols, mono-, oligo- or polysaccharides, salts of
organic or inorganic acids, and absorbant compounds.
The term "cream", as used herein, is intended to indicate any preparation
of sufficient viscosity to remain on the skin for a sufficient period of time
so as to be absorbed into its surface, and' should be understood to include also preparations of appearance other than creamy, such as lotions or
ointments.
According to a preferred embodiment of the invention the additive polyol
is selected from among polyethylene glycol, propylene glycol, polyglycerol,
glycerin, sorbitol, dulcitol, tritol, sorbitol or mannitol.
According to another preferred embodiment of the invention the additive
monosaccharide is selected from among arabinose, ribose, xylose, glucose,
fructose, galactose and mannose.
According to still another preferred embodiment of the invention the
synergistic additive oligosaccharide is selected from among sucrose,
maltose, lactose, raffinose or cellobiose.
According to yet another preferred embodiment of the invention the
additive polysaccharide is selected from among starch or gum arabicum.
The protective agent may contain, according to another preferred
embodiment of the invention, an additive salt selected from among salts of
citric acid, glycolic acid, gluconic acid, tartaric acid, glucaric acid, glyceric
acid, lactic acid, ascorbic acid, thioglycolic acid, benzoic acid, acetic acid,
glycine, alanine, serine, lysine, aspartic acid, cysteine, proline, glutamic
acid, δ-hydroxyl sine, glutamine or urea. The hydrophihc water -based cream of the invention may be of different
types, the important requirements from such base cream being its
hydrophihc nature, and its ability to be spread on the skin and accepted
thereby. For this purpose, glycerin is particularly suitable, since it is
absorbed into the skin and interacts with the epidermis, to provide a
homogeneous and long-lasting protective layer which effectively protects
the skin against sulfur mustard, VX and other chemical insults, even in
the absence of additives.
Without wishing to be bound by any particular theory, it is the inventor's
belief that the action of the cream of the invention is due to its hydrophihc
behavior, which repels sulfur mustard from the skin surface. The addition
of hydrophihc additives of the kind employed in this invention, further
enhance this phenomenon and creates a "salting-out-like" effect toward
the sulfur mustard and other chemical agents. Thus, for instance, the
addition of salts to the cream displaces water molecules and caused a
repulsion of the sulfur mustard or other toxic organic agents away from
the skin.
While, as stated, glycerin is the preferred base for the protective agent
cream, other bases can be used. Cream is defined for the present invention
as a composition having viscosity significantly higher than water. For example, the viscosity of glycerin is 1490-629 centipoise between 20-30°C,
respectively, sorbitol viscosity 110 centipoise at 25°C, while water viscosity
is 1.8 centipoise at 25°C. According to a preferred embodiment of the
invention the hydrophihc water-based cream contains one or more
additives, and the water-based cream consists essentially of a material
selected from among monosaccharides such as sorbitol, potassium
gluconate, potassium tartarate, potassium citrate, calcium chloride or
potassium carbonate. As stated, and as will be further detailed
hereinafter, the cream may contain additional salts, such as MgS04 or
other organic salts, or inorganic salts such as aluminum salts, MgC or
CaCl2, provided that no reaction or precipitation takes place between
them, or surface active agents such as Triton X100, esters of sugars and
lecithin.
While the presence of active materials is not a necessity in the protective
agents of the invention, any suitable active agent can be added. For
instance, the protective agent of the invention may further comprise
antiseptic materials. Furthermore, the protective agent may further
comprise reactive materials, such as nucleophilic materials, e.g.,
thiosulphate, or adsorbent compounds such as bentonite, silica gel,
zeolites. Illustrative and non -limitative examples of reactive materials
include, e.g., dithiophosphate ion, ethanedithiophosphate ion,
hexanedithiophosphate ion, butyldithiophosphate ion, ethyldithiophosphate ion, pentaethylenedithiocarbamate, thiosulphate ion
and dialkylthiophosphate.
Additional reactive agents that may be added to the protective cream are
oxidizing materials. Unstable materials, such as H2O2, may be added on
the spot and may be provided separately from the protective cream. Other
oxidizing agents may be included in the protective cream. Illustrative and
non-limitative examples of oxidizing agents are: perchlorides, peroxides,
sodium percarbonate, H2O2: urea complex, H2O2: PVP
(polyvinylpyrrolidone) complex and magnesium monoperoxy phthalate.
Non-reactive agents may include, for instance, thickening agents such as
methylcellulose, xanthan, carboxy methyl cellulose (CMC), etc.
In another aspect, therefore, the mvention is directed to a method for
protecting the human skin against percutaneous chemical agents such as
sulfur mustard, comprising applying to the skin a protective-effective
amount of a hydrophihc water-based cream, alone or together with one or
more additives selected from among the group consisting essentially of
polyols, mono-, oligo- or polysaccharides, and salts of organic or inorganic
acids. Brief Description of the Drawings
- Fig. 1 is a graphical description of the results obtained in Example 2.
Detailed Description of Preferred Embodiments
The above and other characteristics and advantages of the invention will
be better understood through the following illustrative and non-limitative
examples of preferred embodiments thereof.
General Procedures
Protective creams were tested for efficacy against sulfur mustard lesions
and VX poisoning. The protective potential was tested either against 0.2
and 1 microliter droplets of sulfur mustard applied topically on the back of
pigs' skin, or sulfur mustard vapor or VX (0.2 and 1 microliters). The
extent of cutaneous lesion following liquid sulfur mustard was evaluated
quantitatively using a morphometric and densitometric method with the
aid of an image analyzer.
The area of the damaged skin was measured at 24 hours post exposure
and the protective value of each cream was calculated as a percent of
control of sulfur mustard lesion (0% protection representing identity to the
sulfur mustard lesion). The same test was carried out under sweating
conditions in pigs, and gave almost identical results. When tested against
VX poisoning in pigs, the leathality and clinical signs were monitored and the percent inhibition of acetylcholinesterase (AChE) activity was
measured in blood samples. All the pigs pretreated with the protective
creams survived a 1-5 hours challenge with lethal concentrations (twice
the LD50) of VX and did not exhibit any clinical signs, up to three hours
exposure challenges. In comparison, in the absence of the protective
cream, all animals had severe clinical symptoms and the majority died
within 24-48 hours after exposure to VX. AChE activity was significantly
higher in all animals pretreated with the cream, compared to unprotected
animals. However, some decline in blood AChE activity, induced by
dermal application of VX (1.3 g/Kg, lμl) in pigs was measured in the
treated animals (see Example 2 and Fig.l). The protective creams
provided a significant protection, even when applied 12 hours (single
application) prior to a one hour challenge with Iμl droplets of VX (2 LD50),
or sulfur mustard, when LD50 = 0.65 mg/Kg in pigs, for VX.
Five formulations were tested for irritation in controlled laboratory
studies, and were found to be non-irritating by the Draize procedure in
guinea pigs and rabbits. Three preparations were tested also in Phase I
clinical study, with young male healthy volunteers. The creams were
applied on about 20% of the skin surface. The preparations were found to
be non-irritating and safe for human use. Preparation A
A cream composition containing potassium citrate was prepared using the
following components:
Citric acid monohydrate, 99% (ex Aldrich) 10.5 gr
KOH, 86% (ex Fluka) 8.4 gr
Distilled water 5.0 gr
Glycerin 87% (ex Merck) 20.0 gr
Comparable results were obtained when Glycerin 100% was used.
Preparation B
A cream composition containing potassium acetate was prepared using the
following components:
Potassium acetate (ex Hopkin & Williams) 30.0 gr
Glycerin 87% (ex Merck) 20.0 gr
Preparation C
A cream composition containing sorbitol was prepared using the following
components:
Sorbitol (ex BDH) 30.0 gr
Distilled water 9.0gr Glycerin 87% (ex Merck) 15.0 gr
Preparation D
A cream composition containing potassium β-alanine was prepared using
the following components:
β-alanine, 98% (ex Aldrich) 8.9gr
KOH, 86% (ex Fluka) 5.6 gr
Distilled water 5.0gr
Glycerin 87% (ex Merck) 10.0 gr
Preparation E
A cream composition containing magnesium sulfate was prepared using
the following components:
Magnesium sulfate 10.0 gr
Glycerin 87% (ex Merck) 30.0 gr
Preparation F
A cream composition containing potassium borate was prepared using the
following components:
Sodium borate (Na2B θ7-10H2O) 20.0 gr
Glycerin 87% (ex Merck) 30.0 gr Preparation G
A cream composition containing glycerin was prepared containing only
glycerin 87%.
Preparation H
Magnesium sulfate -7H20 1.5gr
Glycerin 87% 4.5gr
Silica gel 2 gr
Manoxol OT (dioctyl ester of sodium sulfusuccinic acid) 30 mg
Alternative surface active agents
Manoxol OT
Triton x 100
Lecithine
Sodium Lauryl Sulfate
Alternative Adsorb ants
Bentonite
Fumed silica gel
Silica gel
Nanosize- MgO, ZnO, Al203, Ti02
Zeolites
Activated charcoal Example 1
The efficacy of various protective compositions of the invention were
tested according to the general procedure described above. The results are
summarized in Table I below:
Table I
Time of exposure to liquid sulfur mustard
** Time of application of protective agent prior to exposure
Ratio cream component:water:glycerin a NaOH b R-oxothiazolidine-4-carboxylate Example 2
The efficacy of preparation E against VX challenge (twice the LD50, LDso=
0.65 mg/Kg in pigs) was tested in pigs according to the procedure
described above. The results of one of the experiments, where the cream of
preparation E was dermally applied once, 6 hours before a one hour
challenge with 1.3 mg/Kg VX (lμl) are shown in Fig.l.
While embodiments of the invention have been described by way of
illustration, it will be understood that the invention can be carried out by
persons skilled in the art with many modifications, variations and
adaptations, without departing from its spirit or exceeding the scope of the
claims.

Claims (18)

1. A protective agent suitable to protect the human skin against lesions
caused by vesicants or other percutaneous chemical agents, particularly
against sulfur mustard gas injury and VX intoxication, comprising a
protective-effective amount of a hydrophihc water-based cream, alone or
together with one or more additives selected from among the group
consisting essentially of polyols, mono-, oligo- or polysaccharides, and salts
of organic or inorganic acids.
2. A protective agent according to claim 1, wherein the additive polyol is
selected from among polyethylene glycol, propylene glycol, polyglygcerol,
glycerin, sorbitol, dulcitol, tritol, sorbitol or mannitol.
3. A protective agent according to claim 1, wherein the additive
monosaccharide is selected from among arabinose, ribose, xylose, glucose,
fructose, galactose, mannose.
4. A protective agent according to claim 1, wherein the additive
oligosaccharide is selected from among sucrose, maltose, lactose, raffinose
or cellobiose.
5. A protective agent according to claim 1, wherein the additive
polysaccharide is selected from among starch or gum arabicum.
6. A protective agent according to claim 1, wherein the additive salt is
selected from among salts of citric acid, glycolic acid, gluconic acid, tartaric
acid, glucaric acid, glyceric acid, lactic acid, ascorbic acid, thioglycolic acid,
benzoic acid, acetic acid, glycine, alanine, serine, lysine, aspartic acid,
cysteine, proline, glutstoic acid, 8-hydroxylysine or glutamine.
7. A protective agent according to claim 1, wherein the additive salt is
selected from among aluminum salts, MgC or CaGb.
8. A protective agent according to any one of claims 1 to 7, wherein the
hydrophylic water -based cream consists essentially of glycerin.
9. A protective agent according to any one of claims 1 to 7, wherein the
hydrophylic water-based cream contains one or more additives, and
wherein the water-based cream consists essentially of a material selected
from among monosaccharides, potassium gluconate, potassium tartarate,
potassium citrate, calcium chloride or aluminum sulfate.
10. A protective agent according to any one of claims 1 to 9, further
comprising antiseptic materials.
11. A protective agent according to any one of claims 1 to 10, further comprising reactive materials.
12. A protective agent according to claim 11, wherein the reactive material
is a nucleophylic material.
13. A protective agent according to claim 11, wherein the reactive material
is selected from among dithiophosphate ion, ethane dithiophosphate ion,
hexane, dithiophosphate ion, butyl dithiophosphate ion,
ethyldithiophosphate ion, pentaethylenedithiocarbamate, thiosulphate ion
and alkyl dithiophosphate.
14. A protective agent according to claim 11, wherein the reactive material
is an oxidizing agent.
15. A protective agent according to claim 14, wherein the oxidizing agent
is selected from among H2O2, perchlorides, peroxides, sodium
percarbonate, H2O2: urea complex, H2O2: PVP complex and magnesium
monoperoxy phthalate.
16. A method for protecting the human skin against injury caused by
vesicants or other percutaneous chemical agents, comprising applying to
the skin a protective-effective amount of a hydrophylic water-based cream,
alone or together with one or more additives selected from among the group consisting essentially of polyols, mono-, oligo- or polysaccharides,
and salts of organic or inorganic acids.
17. A method according to claim 16, wherein the vesicant is sulfur
mustard gas.
18. A method according to claim 16, wherein the organophosphate is VX.
AU2002217414A 2001-04-25 2001-12-31 Skin-protective compositions effective against vesicants and percutaneous chemical agents Ceased AU2002217414B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL142812 2001-04-25
IL142812A IL142812A (en) 2001-04-25 2001-04-25 High efficacy protective compositions against vesicants and percutaneous chemical agents
PCT/IL2001/001222 WO2002085322A1 (en) 2001-04-25 2001-12-31 Skin-protective compositions effective against vesicants and percutaneous chemical agents

Publications (2)

Publication Number Publication Date
AU2002217414A1 true AU2002217414A1 (en) 2003-04-17
AU2002217414B2 AU2002217414B2 (en) 2008-01-17

Family

ID=11075349

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217414A Ceased AU2002217414B2 (en) 2001-04-25 2001-12-31 Skin-protective compositions effective against vesicants and percutaneous chemical agents

Country Status (9)

Country Link
US (1) US7618616B2 (en)
EP (1) EP1381348B1 (en)
JP (1) JP3874729B2 (en)
KR (1) KR100853443B1 (en)
AT (1) ATE520388T1 (en)
AU (1) AU2002217414B2 (en)
CA (1) CA2444870C (en)
IL (1) IL142812A (en)
WO (1) WO2002085322A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7592002B2 (en) * 2005-10-31 2009-09-22 Bioderm Research Sugar esters for depilation (hair removal), demabrasion, and wrinkles reduction
GB2411833A (en) * 2004-03-08 2005-09-14 Skin Salveation Ltd Composition for use in the treatment of dry skin conditions
US7527784B2 (en) * 2005-08-31 2009-05-05 Bioderm Research Water washable hair removal (depilatory) compositions
US8037550B2 (en) * 2008-02-01 2011-10-18 Gore Enterprise Holdings, Inc. Stretchable chemical protective material
CN110305036B (en) * 2019-01-15 2020-09-04 江南大学 Hydrogen peroxide-responsive nitrogen mustard antitumor prodrug and preparation method thereof
KR102455140B1 (en) 2022-03-29 2022-10-17 국방과학연구소 Reactive skin protection composition that protects against penetration of liquid chemical agents or harmful toxic substances into the skin
KR102551067B1 (en) 2023-03-29 2023-07-04 국방과학연구소 Cleaning composition for reactive skin protecting agent defending against chemical agents and cleaning method using the same

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE470954C (en) 1924-10-24 1929-01-31 Gruenau Landshoff Chem Fab Process for the preparation of an agent suitable for subcutaneous and intravenous injections from lecithin and glycerine
US4107330A (en) * 1969-04-04 1978-08-15 Aaron Leonard Sheffner Topical application of thioglycolic acid in the treatment of acne
US4259318A (en) * 1978-03-02 1981-03-31 University Of Houston, Central Campus Poison ivy relief composition
US4465663A (en) * 1981-07-27 1984-08-14 Basf Wyandotte Corporation Polyoxybutylene-polyoxyethylene aqueous gels
DE3500972A1 (en) * 1985-01-14 1986-07-17 Henkel Kgaa SEBOSUPPRESSIVE COSMETIC AGENTS, CONTAINING ALKOXY OR ALKYLBENZYLOXY BENZOESAEUREN OR THEIR SALTS
GB2237739B (en) * 1985-03-22 1991-10-30 Secr Defence Brit Protective composition
CH672066A5 (en) * 1987-02-20 1989-10-31 Modima Sa
US4850729A (en) * 1987-04-07 1989-07-25 David N. Kramer Decontaminating composition and delivery system therefor
CA1273576A (en) * 1987-09-16 1990-09-04 Patrick A. Beauchamp Topical treatment for diseased skin disorders
US5162378A (en) * 1990-04-20 1992-11-10 Revlon Consumer Products Corporation Silicone containing water-in-oil microemulsions having increased salt content
EP0545002A1 (en) * 1991-11-21 1993-06-09 Kose Corporation Silicone polymer, paste-like composition and water-in-oil type cosmetic composition comprising the same
US5221533A (en) * 1992-01-31 1993-06-22 Perlman H Harris Skin lotion composition
FR2689021B1 (en) * 1992-03-26 1995-09-29 France Etat Armement PROCESS FOR DECONTAMINATION OF SUBSTRATE CONTAMINATED BY TOXIC AGENTS USING A PERSULFATE COMPOSITION.
JPH06279265A (en) 1993-03-29 1994-10-04 Shiseido Co Ltd Transparent gel composition
US5414079A (en) * 1993-08-03 1995-05-09 Biocontrol Incorporated Oxidized cellulose
US5512278A (en) * 1994-01-11 1996-04-30 Phylomed Corporation Ointment base useful for pharmaceutical preparations
DE19528394A1 (en) * 1994-08-13 1996-02-15 Bluecher Hasso Von Removal of chemical warfare agents from skin and materials
US5702709A (en) * 1995-04-18 1997-12-30 Enviroderm Pharmaceuticals, Inc. Skin allergen and irritant barrier lotion
US5607979A (en) * 1995-05-30 1997-03-04 The United States Of America As Represented By The Secretary Of The Army Topical skin protectants
EP0842164A4 (en) * 1995-07-07 1998-10-07 Durham Pharmaceuticals Llc Cyclic amides and derivatives thereof
US5837266A (en) * 1996-04-30 1998-11-17 Hydromer, Inc. Composition, barrier film, and method for preventing contact dermatitis
US6224885B1 (en) * 1996-05-17 2001-05-01 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Barrier cream comprising hexamethylenetetramine or derivative thereof
WO1999049841A1 (en) 1998-03-30 1999-10-07 The Procter & Gamble Company Skin care compositions
ITMI991464A1 (en) * 1999-07-02 2001-01-02 Intercos Italiana SOLID COSMETIC PRODUCT IN NONIONIC WATER-IN-OIL EMULSION
GB9917040D0 (en) 1999-07-21 1999-09-22 Clarke Paul D Antiseptic composition
FR2817761B1 (en) * 2000-12-12 2003-03-14 Irfaq DECONTAMINANT FORMULATION FOR DECONTAMINATION OF THICKENED TOXIC AGENTS

Similar Documents

Publication Publication Date Title
US5753637A (en) Method of treating acne conditions
BR9910168A (en) Antiperspirant compositions containing 1,2 - hexanediol
WO2001085159A1 (en) Topical anti-acne composition
US5910312A (en) Acne treatment composition with vasoconstrictor
US5916574A (en) Method of treating natural poison skin conditions
CA2444870C (en) Skin-protective compositions effective against vesicants and percutaneous chemical agents
CA2265993A1 (en) Novel antimicrobial cosmetic compositions
AU2002217414A1 (en) Skin-protective compositions effective against vesicants and percutaneous chemical agents
US5702709A (en) Skin allergen and irritant barrier lotion
US4404198A (en) Phenyl Salicylate as a topical anti-inflammatory
EP1319387B1 (en) Cosmetic compositions of powder-type containing whitening ingredient
KR20080060924A (en) Low-irritative powder composition for washing
JPS627A (en) Skin external agent containing incorporated urea
EP1736207A1 (en) Depilatory composition
EP3226827B1 (en) Aluminium-free antiperspirant/deodorant compositions and method of preparing the same
DE2456639A1 (en) Sprayable ester contg deodorant compsn - prevents container corrosion without reducing bacteriostatic activity
JPH07138139A (en) Composition for oral cavity application
JP4137020B2 (en) Cosmetics
JP3333428B2 (en) External preparation for skin
RU2164403C1 (en) Protective-and-prophylactic cream
US6436415B2 (en) Herbal deodorant
CA1166958A (en) Poison ivy prevention
JPH0226603B2 (en)
KR19990008898A (en) Hypoallergenic cosmetic composition containing alpha hydroxy acid
MXPA98001210A (en) Barrier lotion against allergens and irritants for the p